Clinical Trials Directory

Trials / Unknown

UnknownNCT03600974

A New System for GERD Diagnosis and Treatment

A New System for Diagnosis and Treatment of Gastroesophageal Refulx Diseases : Based on Endoscopy, pH Parameter, Impedence Parameter, High Resolution Manometry and Psychology

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study measuring a new diagnosis and treatment system "EAISMLP" in adult patients with gastroesophageal reflux disease (GERD).

Detailed description

The investigators created a new diagnosis and treatment system for gastroesophageal reflux disease (GERD). The system based on endoscopy, 24h esophageal pH-impedance monitoring, esophagus high resolution manometry and psycological condition.the investigators named it as "EAISMLP" symptom. Each letter in "EAISMLP" is responsible for a typical character and treatment. Subjects will be subtyped according to "EAISMLP" system and underwent treatment, and will be follow up for 6 months and 1 years.

Conditions

Interventions

TypeNameDescription
PROCEDUREStrettaStretta for Endoscopy-E(+),Acid-A(+),Reflux-symptom association-S(+) or lower oesophageal sphincter-L(+) group
PROCEDURELaparoscopic Nissen fundoplicationLaparoscopic Nissen fundoplication for E(+),A(+) or L(+) group
DRUGProbiotic AgentProbiotic Agent for I(+)G/W;Live Bacillus Licheniformis Cranules 0.5g bid; Bifidbacterium 0.63g bid
DRUGPPIPPIs for A(+),E(+)or S(+) patients: Nexium 20mg Qd/Bid;Lansoprazole 30mg Qd/Bid;omeprazole 10mg-30mg Qd-Bid;Rabeprazole 10mg Qd/Bid;Esomeprazole 20mg Qd/Bid;Pantoprazole 40mg Qd/Bid
DRUGProkinetic Motility AgentsProkinetic Motility Agents for M(+) group; Mosapride 5mg Tid; Domperidone 10mg Tid
DRUGNeuromodulatorsNeuromodulators for P(+) or S(+);Flupentixol and Melitracen 1# bid;

Timeline

Start date
2019-02-01
Primary completion
2020-07-01
Completion
2021-07-01
First posted
2018-07-26
Last updated
2019-02-05

Source: ClinicalTrials.gov record NCT03600974. Inclusion in this directory is not an endorsement.